LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription (original) (raw)

Nature volume 437, pages 436–439 (2005)Cite this article

Abstract

Gene regulation in eukaryotes requires the coordinate interaction of chromatin-modulating proteins with specific transcription factors such as the androgen receptor1. Gene activation and repression is specifically regulated by histone methylation status at distinct lysine residues2. Here we show that lysine-specific demethylase 1 (LSD1; also known as BHC110)3 co-localizes with the androgen receptor in normal human prostate and prostate tumour. LSD1 interacts with androgen receptor in vitro and in vivo, and stimulates androgen-receptor-dependent transcription. Conversely, knockdown of LSD1 protein levels abrogates androgen-induced transcriptional activation and cell proliferation. Chromatin immunoprecipitation analyses demonstrate that androgen receptor and LSD1 form chromatin-associated complexes in a ligand-dependent manner. LSD1 relieves repressive histone marks by demethylation of histone H3 at lysine 9 (H3-K9), thereby leading to de-repression of androgen receptor target genes. Furthermore, we identify pargyline as an inhibitor of LSD1. Pargyline blocks demethylation of H3-K9 by LSD1 and consequently androgen-receptor-dependent transcription. Thus, modulation of LSD1 activity offers a new strategy to regulate androgen receptor functions. Here, we link demethylation of a repressive histone mark with androgen-receptor-dependent gene activation, thus providing a mechanism by which demethylases control specific gene expression.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Glass, C. K. & Rosenfeld, M. G. The coregulator exchange in transcriptional function of nuclear receptors. Genes Dev. 14, 121–141 (2000)
    CAS PubMed Google Scholar
  2. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000)
    Article ADS CAS PubMed Google Scholar
  3. Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941–953 (2004)
    Article CAS PubMed Google Scholar
  4. Shi, Y. et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735–738 (2003)
    Article ADS CAS PubMed Google Scholar
  5. Hakimi, M. A. et al. A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J. Biol. Chem. 278, 7234–7239 (2003)
    Article CAS PubMed Google Scholar
  6. Hakimi, M. A. et al. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc. Natl Acad. Sci. USA 99, 7420–7425 (2002)
    Article ADS CAS PubMed PubMed Central Google Scholar
  7. Eimer, S. et al. Loss of spr-5 bypasses the requirement for the C. elegans presenilin sel-12 by derepressing hop-1. EMBO J. 21, 5787–5796 (2002)
    Article CAS PubMed PubMed Central Google Scholar
  8. Müller, J. M. et al. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19, 359–369 (2000)
    Article PubMed PubMed Central Google Scholar
  9. Müller, J. M. et al. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J. 21, 736–748 (2002)
    Article PubMed PubMed Central Google Scholar
  10. Shang, Y., Myers, M. & Brown, M. Formation of the androgen receptor transcription complex. Mol. Cell 9, 601–610 (2002)
    Article CAS PubMed Google Scholar
  11. Shatkina, L. et al. The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor. Mol. Cell. Biol. 23, 7189–7197 (2003)
    Article CAS PubMed PubMed Central Google Scholar
  12. Kang, Z., Pirskanen, A., Jänne, O. A. & Palvimo, J. J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277, 48366–48371 (2002)
    Article CAS PubMed Google Scholar
  13. Metzger, E. et al. A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J. 22, 270–280 (2003)
    Article CAS PubMed PubMed Central Google Scholar
  14. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957–8961 (2003)
    Article CAS PubMed PubMed Central Google Scholar
  15. Pfaffl, M. W., Horgan, G. W. & Dempfle, L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36 (2002)
    Article PubMed PubMed Central Google Scholar
  16. O'Neill, T. E., Roberge, M. & Bradbury, E. M. Nucleosome arrays inhibit both initiation and elongation of transcripts by bacteriophage T7 RNA polymerase. J. Mol. Biol. 223, 67–78 (1992)
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

We thank T. Benzing, F. Claessens, T. Jenuwein, Z. Sun and D. Trono for providing reagents. We are obliged to the members of the Schüle laboratory for discussions. We thank K. Fischer, P. Kahl and L. Heukamp for technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft and Deutsche Krebshilfe to R.S.

Author information

Author notes

  1. Melanie Wissmann and Na Yin: *These authors contributed equally to this work

Authors and Affiliations

  1. Universitäts-Frauenklinik und Zentrum für Klinische Forschung, Klinikum der Universität Freiburg, Breisacherstrasse 66, 79106, Freiburg, Germany
    Eric Metzger, Melanie Wissmann, Na Yin, Judith M. Müller, Thomas Günther & Roland Schüle
  2. Max-Planck-Institut für Immunbiologie, Stübeweg 51, 79108, Freiburg, Germany
    Robert Schneider
  3. Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Maulbeerstrasse 66, 4058, Basel, Switzerland
    Antoine H. F. M. Peters
  4. Institut für Pathologie, Universitätsklinikum Bonn, Sigmund-Freud-Strasse 25, 53127, Bonn, Germany
    Reinhard Buettner

Authors

  1. Eric Metzger
    You can also search for this author inPubMed Google Scholar
  2. Melanie Wissmann
    You can also search for this author inPubMed Google Scholar
  3. Na Yin
    You can also search for this author inPubMed Google Scholar
  4. Judith M. Müller
    You can also search for this author inPubMed Google Scholar
  5. Robert Schneider
    You can also search for this author inPubMed Google Scholar
  6. Antoine H. F. M. Peters
    You can also search for this author inPubMed Google Scholar
  7. Thomas Günther
    You can also search for this author inPubMed Google Scholar
  8. Reinhard Buettner
    You can also search for this author inPubMed Google Scholar
  9. Roland Schüle
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toRoland Schüle.

Ethics declarations

Competing interests

Reprints and permissions information is available at npg.nature.com/reprintsandpermissions. The authors declare no competing financial interests.

Supplementary information

Supplementary Notes

Contains Supplementary Methods (plasmids, immunofluorescence, in vitro pull-down assays, mRNAanalyses, tandem affinity purification) and the legends for the Supplementary Figures. (DOC 41 kb)

Supplementary Figure S1

a, Coomassie blue staining reveals that LSD1 (arrow) is co-purified with TAP-FHL2 (arrow) during tandem affinity purification. b, Western blot analysis using -LSD1 antibody. (PDF 113 kb)

Supplementary Figure S2

LSD1 expression analyses. (PDF 88 kb)

Supplementary Figure S3

LSD1 interacts with chromatin. (PDF 82 kb)

Supplementary Figure S4

LNCaP cells were incubated with or without R1881 and treated with or without pargyline. (PDF 229 kb)

Supplementary Figure S5

siRNA mediated knockdown of LSD1. (PDF 52 kb)

Supplementary Figure S6a-h

Specificity of LSD1 in the control of AR-induced transcriptional activity. (PDF 15 kb)

Supplementary Figure S6i-k

Specificity of LSD1 in the control of AR-induced transcriptional activity. (PDF 8 kb)

Rights and permissions

About this article

Cite this article

Metzger, E., Wissmann, M., Yin, N. et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.Nature 437, 436–439 (2005). https://doi.org/10.1038/nature04020

Download citation

This article is cited by